mTORC1 and mTORC2 involvement in activation of MAPK pathway via a PI3K/AKT-dependent feedback loop influences glioblastoma multiforme dissemination

被引：0
|
作者：
Albert, Ladislau [1 ]
Karsy, Michael [1 ]
Gulati, Nicholas [1 ]
Geis, Mera D. [1 ]
Braun, Alex [1 ]
Murali, Raj [1 ]
Jhanwar-Uniyal, Meena [1 ]
机构：
[1] New York Med Coll, Dept Neurosurg, Valhalla, NY 10595 USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2856
引用
收藏
页数：1
相关论文
共 50 条
  • [1] mTORC1 inhibition with rapamycin leads to activation of PI3K/AKT signalling via an mTORC2 dependent mechanism in melanoma cells
    Werzowa, J.
    Pratscher, B.
    Cejka, D.
    Pehamberger, H.
    Wacheck, V.
    EJC SUPPLEMENTS, 2006, 4 (12): : 176 - 177
  • [2] Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility
    Gulati, Nicholas
    Karsy, Michael
    Albert, Ladislau
    Murali, Raj
    Jhanwar-Uniyal, Meena
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (04) : 731 - 740
  • [3] RES-529: a PI3K/AKT/mTOR pathway inhibitor that dissociates the mTORC1 and mTORC2 complexes
    Weinberg, Mark A.
    ANTI-CANCER DRUGS, 2016, 27 (06) : 475 - 487
  • [4] Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
    Carracedo, Arkaitz
    Ma, Li
    Teruya-Feldstein, Julie
    Rojo, Federico
    Salmena, Leonardo
    Alimonti, Andrea
    Egia, Ainara
    Sasaki, Atsuo T.
    Thomas, George
    Kozma, Sara C.
    Papa, Antonella
    Nardella, Caterina
    Cantley, Lewis C.
    Baselga, Jose
    Pandolfi, Pier Paolo
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (09): : 3065 - 3074
  • [5] Prolonged deprivation of arginine or leucine induces PI3K/ Akt-dependent reactivation of mTORC1
    Buel, Gwen R.
    Dang, Huy Q.
    Asara, John M.
    Blenis, John
    Mutvei, Anders P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2022, 298 (06)
  • [6] Factors predisposing to development of hyperglycaemia in phase 1 studies involving PI3K, mTOR, AKT and mTORC1 and mTORC2 inhibitors
    Wong, M.
    Khan, K. H.
    Rihawi, K.
    Bodla, S.
    Amin, B.
    Shah, K.
    Morganstein, D.
    Kaye, S. B.
    Banerji, U.
    Molife, L. R.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S180 - S180
  • [7] PI3K/Akt promotes feedforward mTORC2 activation through IKKα
    Dan, Han C.
    Antonia, Ricardo J.
    Baldwin, Albert S.
    ONCOTARGET, 2016, 7 (16) : 21064 - 21075
  • [8] Vertical Inhibition of the mTORC1/mTORC2/PI3K Pathway Shows Synergistic Effects against Melanoma In Vitro and In Vivo
    Werzowa, Johannes
    Koehrer, Stefan
    Strommer, Sabine
    Cejka, Daniel
    Fuereder, Thorsten
    Zebedin, Eva
    Wacheck, Volker
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (02) : 495 - 503
  • [9] Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway
    Nathan, Neera
    Keppler-Noreuil, Kim M.
    Biesecker, Leslie G.
    Moss, Joel
    Darling, Thomas N.
    DERMATOLOGIC CLINICS, 2017, 35 (01) : 51 - +
  • [10] Inpp5e suppresses polycystic kidney disease via inhibition of PI3K/Akt-dependent mTORC1 signaling
    Hakim, Sandra
    Dyson, Jennifer M.
    Feeney, Sandra J.
    Davies, Elizabeth M.
    Sriratana, Absorn
    Koenig, Monica N.
    Plotnikova, Olga V.
    Smyth, Ian M.
    Ricardo, Sharon D.
    Hobbs, Robin M.
    Mitchell, Christina A.
    HUMAN MOLECULAR GENETICS, 2016, 25 (11) : 2295 - 2313
12345